MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report insinuates that the Middle East and Africa’s pharmaceutical continuous manufacturing market is expected to foster growth in revenue at a compound annual growth rate of 9.97% through the years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

The Middle East and Africa region is estimated to offer lucrative opportunities for prominent market players due to the rising target population, growth in the demand for pharmaceutical products, and enhanced healthcare infrastructure. In Saudi Arabia, the pharmaceutical industry is among the largest in GCC countries, with drugs manufactured abroad accounting for most of the market.

Additionally, several reforms have been introduced by the government to fuel the growth of the pharma industry. For instance, the government launched 100 percent FDI in the sector that would surge the total local production of pharmaceutical products across the country. Therefore, the growing government efforts to limit pharmaceutical spending and encourage local production is expected to motivate the growth of the pharmaceutical continuous manufacturing market across Saudi Arabia over the assessed period.

On the other hand, the pharma sector is likely to witness significant growth to meet a surging population’s changing needs in the United Arab Emirates. Moreover, the country has high import levels, which has compelled the government to augment the local manufacturing of pharmaceutical products in the country. Besides, the government authorities are also concentrating on attracting foreign pharma companies to set up and extend their presence across the country. As stated above, these factors are anticipated to amplify the pharmaceutical continuous manufacturing market’s progress across the United Arab Emirates.

Pfizer Inc is a biopharmaceutical company involved in developing, manufacturing, and distributing several products, including medicines, consumer healthcare products, and vaccines. Its comprehensive product portfolio includes products used to treat conditions, such as cardiovascular disease, infection, cancer, tissue repair, orphan diseases, and genitourinary disorders. The company’s continuous manufacturing plant is an innovative, technologically advanced facility dedicated to tablet production. It has operations in multiple regions, including Middle East and Africa region.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. MARKET ATTRACTIVENESS INDEX

2.4. VENDOR SCORECARD

2.5. KEY INSIGHTS

2.6. MARKET DRIVERS

2.6.1.   RISE IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.6.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.6.3.   RISING HEALTHCARE EXPENDITURE

2.7. MARKET RESTRAINTS

2.7.1.   LACK OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES

2.7.2.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.8. MARKET OPPORTUNITIES

2.8.1.   INCREASING OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES

2.8.2.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - MIDDLE EAST AND AFRICA

6.1. COUNTRY ANALYSIS

6.1.1. SAUDI ARABIA

6.1.2. UNITED ARAB EMIRATES

6.1.3. TURKEY

6.1.4. SOUTH AFRICA

6.1.5. REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMO FISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 3:       MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4:       MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 5:       MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 11:  UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 12:  TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 13:  SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 14:  REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;